CHRNA3/5, IREB2, and ADCY2 are associated with severe chronic obstructive pulmonary disease in Poland.
about
Gain-of-function ADCY5 mutations in familial dyskinesia with facial myokymiaGSTCD and INTS12 regulation and expression in the human lungCandidate genes for COPD: current evidence and researchRisk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis.Increased iron sequestration in alveolar macrophages in chronic obstructive pulmonary diseaseEpac1 and Epac2 are differentially involved in inflammatory and remodeling processes induced by cigarette smoke.Molecular cloning, sequence identification, and gene expression analysis of bovine ADCY2 gene.Association of genetic polymorphisms with chronic obstructive pulmonary disease in the Chinese Han population: a case-control studyAssociation of genetic polymorphisms with chronic obstructive pulmonary disease in the Hainan population: a case-control studyGene susceptibility identification in a longitudinal study confirms new loci in the development of chronic obstructive pulmonary disease and influences lung function decline.A genome-wide association study identifies risk loci for spirometric measures among smokers of European and African ancestry.Integrating Multiple Correlated Phenotypes for Genetic Association Analysis by Maximizing HeritabilityVariants in multiple genes polymorphism association analysis of COPD in the Chinese Li population.Susceptibility loci in lung cancer and COPD: association of IREB2 and FAM13A with pulmonary diseases.The role of iron in pulmonary pathology.Association of IREB2 Gene rs2568494 Polymorphism with Risk of Chronic Obstructive Pulmonary Disease: A Meta-Analysis.Mitochondrial iron chelation ameliorates cigarette smoke-induced bronchitis and emphysema in mice.Genome-wide association study identifies TH1 pathway genes associated with lung function in asthmatic patients.Molecular mechanisms underlying variations in lung function: a systems genetics analysis.Heterogeneity of chronic obstructive pulmonary disease: from phenotype to genotype.Moving beyond genetics: is FAM13A a major biological contributor in lung physiology and chronic lung diseases?Chronic Obstructive Pulmonary Disease Genetics: A Review of the Past and a Look Into the FutureInternational Union of Basic and Clinical Pharmacology. CI. Structures and Small Molecule Modulators of Mammalian Adenylyl Cyclases.The IRONy of Iron-overload and Iron-deficiency in Chronic Obstructive Pulmonary Disease.IREB2, CHRNA5, CHRNA3, FAM13A & hedgehog interacting protein genes polymorphisms & risk of chronic obstructive pulmonary disease in Tatar population from Russia.Genetic Variants in the Hedgehog Interacting Protein Gene Are Associated with the FEV1/FVC Ratio in Southern Han Chinese Subjects with Chronic Obstructive Pulmonary Disease.DNA methylation profiling in human lung tissue identifies genes associated with COPD.Suxiao Jiuxin Pill protects cardiomyocytes against mitochondrial injury and alters gene expression during ischemic injury.Severe COPD cases from Korea, Poland, and USA have substantial differences in respiratory symptoms and other respiratory illnesses.Understanding the role of the chromosome 15q25.1 in COPD through epigenetics and transcriptomics.Ensemble genomic analysis in human lung tissue identifies novel genes for chronic obstructive pulmonary disease.Exon sequencing identifies a novel CHRNA3-CHRNA5-CHRNB4 variant that increases the risk for chronic obstructive pulmonary disease.Trade-offs in aging lung diseases: a review on shared but opposite genetic risk variants in idiopathic pulmonary fibrosis, lung cancer and chronic obstructive pulmonary disease.Chronic Obstructive Pulmonary Disease Meta Genome-Wide Association Studies. New Insights into the Genetics of Chronic Obstructive Pulmonary Disease.Association of lung function genes with chronic obstructive pulmonary disease.Association of five genetic variants with chronic obstructive pulmonary disease susceptibility and spirometric phenotypes in a Chinese Han population.Receptor for advanced glycation end products and soluble receptor for advanced glycation end products: a balancing act in chronic obstructive pulmonary disease?Genetic variants in FAM13A and IREB2 are associated with the susceptibility to COPD in a Chinese rural population: a case-control study.
P2860
Q24293635-02EBD442-F132-480A-891F-BD41B666DC26Q24337095-EFC14AF8-0A4D-4EF0-A2A7-D6C289A96344Q26777324-8E93C4C0-3C9C-4F42-B716-3011EA98E0A8Q29416987-5D94176D-25D0-4014-8F3C-A61A615E2D87Q33553600-A0246979-51DE-4ACF-9DB6-D8317F1FB007Q34356136-1628FE5B-6D4D-4457-B545-33DB509DA589Q34418899-526D1420-F519-455E-853F-A1DB29EFEA03Q34522806-E43F2F4D-FFB6-43FD-B672-8D8F60D08C2AQ34787172-40AE4503-3E45-483C-B3EF-9F5561232819Q35595026-1D46617E-A8B2-40DD-8DF1-24A7C16ACC6FQ35860362-B7EDDCC3-9B92-4470-8B8B-9E8780D01788Q35868427-B2B0FCB2-5821-49D2-A6EA-C762A3B24205Q35914781-92E79882-41A7-401E-A88C-4957399A0DD3Q35999518-FAF18825-A7F3-4535-AAD1-E4FDED541006Q36336719-F3D3EBE3-38D1-4E7B-B68F-9CEB1D55A967Q36490727-D5BE161F-2BF6-440A-AF24-ED609C88B8EDQ36547252-E561FB99-28A3-4A99-8F65-5C25E8C6B780Q37102310-2D0513F4-EAD0-4DC5-9D9C-5460A8AF4177Q37252370-0BF685F0-1CD3-411F-9EDF-B01191790F7FQ38162802-5BD10A4C-79B1-4ACA-B84C-3D2294752CFFQ38243943-1C00A6BE-4E3A-4765-81BE-FEB3B9F0D9BCQ38636068-6F99A7BE-78A3-442E-B4BA-7167305E83E1Q39158851-862301C5-E6DA-4689-A27E-C05300FFE3F9Q39243181-ADCB1D8B-0397-435E-9D00-2CCD7A572DCAQ40214159-7C22C61E-619D-418A-9063-6328FFF6EF95Q41449935-2BFE4FEB-EE71-44F4-A801-3B924112DDC1Q41665058-B033522A-40BF-4F10-9F8F-26EE98409530Q42376394-E424D4D6-EA44-42DE-AA2A-FC5AAF545A59Q47109204-25003B50-857F-4C20-91DE-059735C8E30AQ49026661-4E84D52C-E4C2-4110-994C-D91E439B4BC2Q50044127-17DC59B7-6A84-4E60-B0A9-A778AACE9A4DQ51638772-4E9E71E9-78C0-4E34-817B-43E693B7AAC1Q51764891-932B5FC3-8330-47B5-B38D-A17CFAB758F9Q53186860-B8A3D67C-1A34-4942-AA98-38B8C47A3F3BQ53286287-9A15F8F4-BE47-4CA9-9B9D-277D8D9D7ED6Q54522045-89348D4A-A251-4968-821F-E653485087E3Q54757715-221F3A6C-2D40-4A6E-B107-8349842B7001Q55332454-77F955B2-4FD1-4AA9-AC07-4C116F1633C7
P2860
CHRNA3/5, IREB2, and ADCY2 are associated with severe chronic obstructive pulmonary disease in Poland.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
CHRNA3/5, IREB2, and ADCY2 are ...... e pulmonary disease in Poland.
@ast
CHRNA3/5, IREB2, and ADCY2 are ...... e pulmonary disease in Poland.
@en
type
label
CHRNA3/5, IREB2, and ADCY2 are ...... e pulmonary disease in Poland.
@ast
CHRNA3/5, IREB2, and ADCY2 are ...... e pulmonary disease in Poland.
@en
prefLabel
CHRNA3/5, IREB2, and ADCY2 are ...... e pulmonary disease in Poland.
@ast
CHRNA3/5, IREB2, and ADCY2 are ...... e pulmonary disease in Poland.
@en
P2093
P2860
P356
P1476
CHRNA3/5, IREB2, and ADCY2 are ...... e pulmonary disease in Poland.
@en
P2093
Craig P Hersh
Edwin K Silverman
Emily S Wan
Eric Schwinder
Iwona Hawrylkiewicz
Jan Zielinski
Megan Hardin
Michael H Cho
Pawel Sliwinski
Peter J Castaldi
P2860
P304
P356
10.1165/RCMB.2012-0011OC
P577
2012-03-29T00:00:00Z